FDA — authorised 20 December 2019
- Marketing authorisation holder: EISAI INC
- Status: approved
🇺🇸 Dayvigo in United States
FDA authorised Dayvigo on 20 December 2019
Marketing authorisations
FDA — authorised 11 March 2022
- Application: NDA212028
- Marketing authorisation holder: EISAI INC
- Indication: Labeling
- Status: approved
Dayvigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Dayvigo approved in United States?
Yes. FDA authorised it on 20 December 2019; FDA authorised it on 11 March 2022.
Who is the marketing authorisation holder for Dayvigo in United States?
EISAI INC holds the US marketing authorisation.